NCT00575159View on ClinicalTrials.gov

A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

December 18, 2008

Study Completion Date

December 18, 2008

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

GSK189075

investigational drug

DRUG

placebo

placebo comparator

Trial Locations (1)

92161

GSK Investigational Site, San Diego

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY